Aerse Ete Pankaj Amin

FDA investigator

Appears on 1 document from 2022, mostly at sites in Pennsylvania. Most often cites packaging and labeling operations (21 CFR 211.130).

1
Documents on file
2.0
Observations per 483
2022
First seen
2022
Most recent

What they cite most

From 2 observations

Activity by year

2022: 1

Where

Pennsylvania 1

Often inspects with

Burnell M. Henry

Is Aerse Ete Pankaj Amin coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

1 document, newest first
FirmOpen
483 Corixa Corporation d.b.a. GlaxoSmithKlineMar 4, 2022 · Marietta, Pennsylvania

About this profile

What does Aerse Ete Pankaj Amin inspect?

Aerse Ete Pankaj Amin appears on 1 document on file covering 1 site, mostly in Pennsylvania.

What do they cite most often?

21 CFR 211.130 (packaging and labeling operations), followed by 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Aerse Ete Pankaj Amin is dated Mar 4, 2022.

FDA Investigator Aerse Ete Pankaj Amin: 483s & Inspections · FDA Intel